Navigation Links
PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
Date:4/2/2013

BOSTON, April 2, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2013 on Tuesday, April 30, 2013 after the close of the stock market.  The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PR Newswire website at www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Wednesday, May 1, 2013 to discuss the results.  To access the webcast, visit PAREXEL's website at www.PAREXEL.com, and click on the Investors menu.  This webcast will continue to be accessible for one year following the live broadcast.  To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL's Third Quarter Fiscal Year 2013 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 74 locations throughout 51 countries around the world, and has approximately 14,000 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.

Contacts:
James Winschel , Senior Vice President and Chief Financial Officer
Jill Baker , Corporate Vice President, Investor Relations
+1-781-434-4118
Email: Jill.Baker@parexel.com


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL International to Present at Morningstar Conference
2. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
3. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
4. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
5. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
6. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
7. PAREXEL International to Present at J.P. Morgan Healthcare Conference
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
10. Burns Engineering Announces Expanded Selection of Miniature Temperature Sensors
11. LabRoots Announces New Cell Biology Image Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara ... determination of FXIII. , Aniara Diagnostica, a multi-national distributor of diagnostic and research ... highest standards for product quality and cost-efficient delivery. , For Research ...
(Date:4/7/2020)... ... 2020 , ... Gateway Genomics , leading developer of direct-to-consumer genetic tests ... DNA Tests sold in March, just months after attaining the 150,000-test landmark in ... a mom could order her kit online, collect a DNA sample from her home, ...
(Date:4/1/2020)... ... March 30, 2020 , ... A joint venture ... (RID), formed earlier this year to bring telehealth to various government agencies, has ... COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from the ...
(Date:4/1/2020)... DANBURY, Conn. (PRWEB) , ... March 31, 2020 ... ... P2 Science, Inc. (P2) announce the signing of a Joint Development Agreement ... pheromones. , Bedoukian Research, Inc. is a global leader in the supply of ...
Breaking Biology Technology:
(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. ... firm that provides patent development support for early stage startups. The investment will ... as ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. ...
(Date:4/18/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... April 16, 2020 , ... ... technologies for gene and cell therapy, today announced it will present a company update ... April 2020 Virtual Investor Summit taking place on April 22 and 23. Dieter ...
(Date:4/16/2020)... ... April 15, 2020 , ... RoosterBio Inc., a ... bioprocess systems, announces that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution ... Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team ...
Breaking Biology News(10 mins):